The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer

Background: In various tumor entities, expression of cancer stem cell (CSC) antigens has been proven to be prognostically unfavorable. However, for lung cancer, the data are scant and conflicting. Patients and Methods: The CSC antigens CD117/c-KIT, CD133 and breast cancer resistance protein-1 (BCRP1...

Full description

Bibliographic Details

Main Authors:	Herpel, Esther (Author) , Jensen, Katrin (Author) , Muley, Thomas (Author) , Warth, Arne (Author) , Schnabel, Philipp Albert (Author) , Meister, Michael (Author) , Herth, Felix (Author) , Dienemann, Hendrik (Author) , Thomas, Michael (Author) , Gottschling, Sandra (Author)
Format:	Article (Journal)
Language:	English
Published:	[December 2011]
In:	Anticancer research Year: 2011, Volume: 31, Issue: 12, Pages: 4491-4500
ISSN:	1791-7530
Online Access:	Verlag, lizenzpflichtig, Volltext: https://ar.iiarjournals.org/content/31/12/4491
Author Notes:	Esther Herpel, Katrin Jensen, Thomas Muley, Arne Warth, Philipp A. Schnabel, Michael Meister, Felix J. F. Herth, Hendrik Dienemann, Michael Thomas and Sandra Gottschling